The family is coming!
Release time:
2020-11-12
The family is coming!
10# On March 28, I went to Anhui Xinbeika Chemical Co., Ltd. with two colleagues to participate in the bidding for cables, and had the honor to see the peak API production base.
There is another story about this tender. It was at a semi-annual business analysis meeting of the group company last year. Zhang Ci, general manager of the cable company, suggested that our Jianfeng Group has so many projects under construction that we will definitely use cables. Companies within the group should support each other and try to use cables that their own companies can produce. Not only are the quality assured, but also the service is guaranteed. Coincidentally, sitting next to Mr. Zhang was Mr. Kang of Shanghai North Carolina Company. He was the first to express his support to Mr. Zhang. As a result, the two companies had business contacts and had this bidding.arrived at the door of the new North Card and saw two mighty lions. Next to the office building stood a large schematic diagram of the completion of the project. When I got to the parking lot, I found that there were still many "Zhejiang G" license plates. I think most of them should also be colleagues from Jinhua.
As soon as we walked to the door of the office building, we met a horse worker. We were very surprised. Ma Gong used to work under the same roof as us in the health technology company, and he was very kind to encounter him in another country. When I went to the office of the purchasing department, I met Mr. Gao, who was in charge of purchasing. she warmly received us and said as soon as she saw us, "our family is coming!" The office became lively. She said that Xiao Cao from our project department, Xiao Lu from the production department and Xiao Xia from the finance department all came from Jinhua and asked them to get together in the evening.
After the bidding was over, Xiao Cao and Ma Gong took us to the construction site of Phase II for a tour. The construction site is in full swing, high-rise buildings are rising from the ground, the infrastructure project is nearing completion, the planning layout has been finalized, and the installation of equipment has entered the stage. Xiao Cao is a sunny and handsome young man. He has been here for three years and has witnessed all the changes with his own eyes. Therefore, he knows the construction of this site well and introduces us to the future functions of each building one by one. We can also hear the hometown dialect here, and we feel very kind.
In the evening, Gao Zong arranged a sumptuous meal for us and invited colleagues from Jinhua to meet. Gao is always a very friendly person. Everyone is unrestrained, talking and laughing, and the fatigue of a day's work has disappeared. The factory area of Xinbeika is four kilometers away from the nearest town. They all live in the town. The town is small and there are no entertainment places. I asked them what kind of recreation and entertainment they usually have after work, and they replied: the most common way of recreation is to work overtime, and busy working hours will pass faster. Make us laugh, but the heart is raised a respect, is a tribute to the peak entrepreneurs. Before
came, Zhang always asked us to bring some Jinhua crisp cakes, which was also a little bit of a gift from his family to these peak entrepreneurs. (Lu Chaofang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page